Mobile Logo in White

Benzinga: Plus Therapeutics Announces Initial Patients Successfully Treated in ReSPECT-LM Dose Optimization Trial for REYOBIQ™ in Leptomeningeal Metastases

Andrew Brenner, MD, PhD, professor and chair of neuro-oncology research with UT Health San Antonio’s Mays Cancer Center, was quoted in this article.

 

Read More



Share This Article!
Categories:
Secured By miniOrange